The University of Southampton
University of Southampton Institutional Repository

Studies on the expression and regulation of transcription factors in hepatic stellate cells

Studies on the expression and regulation of transcription factors in hepatic stellate cells
Studies on the expression and regulation of transcription factors in hepatic stellate cells

A key event in the pathogenesis of liver fibrosis is the activation of hepatic stellate cells (HSCs). Three major transcription factors (MyoD, Sp1 and AP-1) that may be important regulators of HSC activation have been analysed.

Both in vitro and in vivo models of HSC activation were associated with changes in E-box DNA binding activities. Freshly isolated HSCs from untreated rats expressed a high mobility complex (C) that was replaced upon activation with two low mobility complexes (A and B). The assembly of complexes A and B was inhibited with an antibody against MyoD. Further studies demonstrated that HSCs did express the transcription factor, MyoD, and its expression may be controlled by a post-transcription mechanism.

Both in vitro and in vivo models of HSC activation revealed induction of a low mobility GC-box (LMGC) binding complex and was subsequently identified as Sp1.

Culture activation of rat HSCs (in vitro) indicated transient expression of low mobility AP-1 (LMAP-1) complexes that were maximally induced at 24 hours of culture and then fell to undetectable levels with further culture. Supershift Electromobility Shift Assay (EMSA) identified its components as c-Jun, JunD, c-Fos and FosB. Further culture of HSCs led to the detection of sustained high mobility AP-1 (HMAP-1) complexes. Supershift EMSA described these proteins as JunD, Fra2 and FosB. Finally, in vivo studies revealed a slightly different AP-1 profile where the complexes consisted of JunB, JunD, Fra1 and Fra2.

Further experiments are now required to elucidate the functions of these transcription factors in the HSC. Greater understanding of the molecular events that underlie liver fibrosis may lead to the development of new therapeutic strategies in the future.

University of Southampton
Vincent, Karen Jane
0a7c5857-18ea-4e41-a5ba-441b80859bef
Vincent, Karen Jane
0a7c5857-18ea-4e41-a5ba-441b80859bef

Vincent, Karen Jane (2000) Studies on the expression and regulation of transcription factors in hepatic stellate cells. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

A key event in the pathogenesis of liver fibrosis is the activation of hepatic stellate cells (HSCs). Three major transcription factors (MyoD, Sp1 and AP-1) that may be important regulators of HSC activation have been analysed.

Both in vitro and in vivo models of HSC activation were associated with changes in E-box DNA binding activities. Freshly isolated HSCs from untreated rats expressed a high mobility complex (C) that was replaced upon activation with two low mobility complexes (A and B). The assembly of complexes A and B was inhibited with an antibody against MyoD. Further studies demonstrated that HSCs did express the transcription factor, MyoD, and its expression may be controlled by a post-transcription mechanism.

Both in vitro and in vivo models of HSC activation revealed induction of a low mobility GC-box (LMGC) binding complex and was subsequently identified as Sp1.

Culture activation of rat HSCs (in vitro) indicated transient expression of low mobility AP-1 (LMAP-1) complexes that were maximally induced at 24 hours of culture and then fell to undetectable levels with further culture. Supershift Electromobility Shift Assay (EMSA) identified its components as c-Jun, JunD, c-Fos and FosB. Further culture of HSCs led to the detection of sustained high mobility AP-1 (HMAP-1) complexes. Supershift EMSA described these proteins as JunD, Fra2 and FosB. Finally, in vivo studies revealed a slightly different AP-1 profile where the complexes consisted of JunB, JunD, Fra1 and Fra2.

Further experiments are now required to elucidate the functions of these transcription factors in the HSC. Greater understanding of the molecular events that underlie liver fibrosis may lead to the development of new therapeutic strategies in the future.

Text
744660.pdf - Version of Record
Available under License University of Southampton Thesis Licence.
Download (22MB)

More information

Published date: 2000

Identifiers

Local EPrints ID: 466958
URI: http://eprints.soton.ac.uk/id/eprint/466958
PURE UUID: c5512498-16e9-4da7-bae2-98b7c8844fa9

Catalogue record

Date deposited: 05 Jul 2022 08:04
Last modified: 16 Mar 2024 20:53

Export record

Contributors

Author: Karen Jane Vincent

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×